Skip to main content

Table 3 Benefits and Value of Cancer Screenings Since USPSTF Recommendations Considering Adherence

From: The aggregate value of cancer screenings in the United States: full potential value and value considering adherence

Cancer Type

Total Cohort Size of Eligible Individuals Considering Adherence

(millions of people)

Life-Years Gained Considering Adherence

(millions of life years)

Value of the Life-Years Gained Considering Adherence

($ trillions)

Breast

55–81

1.6–3.6

$0.8-$1.9

Colorectal

78–85

0.7–1.9

$0.4-$1.0

Cervical

111

9.9–10.6

$5.2-$5.7

Lung

2.4

0.08

$0.04

Total

244–278

12.2–16.2

$6.5-$8.6

  1. USPSTF, US Preventive Services Task Force